1 What is in the Water and What are the Risks? Bryan W. Brooks, Ph.D. Associate Professor and Director Environmental Health Science Program Texas Innovative.

Slides:



Advertisements
Similar presentations
Pharmaceuticals and Personal Care Products in the Environment: What are the Key Research Questions? Alistair BA Boxall, Murray A Rudd, Bryan W Brooks,
Advertisements

Perspectives from EPA’s Endocrine Disruptor Screening Program
Tara Duffy and Stephen McCormick Conte Anadromous Fish Research Lab, Turners Falls, MA Differential life-stage response to common endocrine disruptors.
Pharmaceuticals as environmental pollutants – current situation and ongoing research Christina Rudén Royal Institute of Technology (KTH)
An Evaluation of Models to Predict the Activity of Environmental Estrogens Candice M. Johnson and Rominder Suri, Ph.D.,P.E. NSF Water and Environmental.
Disposal of Unused or Expired Drugs Attorneys General Education Program Public Policy Conference THE PHARMACEUTICAL INDUSTRY: ECONOMICS, REGULATION, AND.
1 Post-UNEP/WHO EDC State of the Science 2012 report Personal reflections by Åke Bergman, coordinator of the above mentioned report, IPCP vice chair and.
TRP Chapter Chapter 2.3 Environmental impacts and health risks.
Session III: Assessing Cumulative Effects of Endocrine Active Substances 9:15 - 9:30 Introduction” Rick Becker (Session Chair and Panel Moderator) 9:30.
Pharmaceuticals in Drinking Water Nancy Mesner Aquatic, Watershed and Earth Resources Utah State University.
Paracelsus “The dose makes the poison ”. MSDS Environmental Hazards and Human Health Chapter 17.
The Effects of Caffeine and Triclocarban on Gammarus pseudolimnaeus Jim Fietzer Department of Biological Sciences, University of Wisconsin – Whitewater.
Pharmaceuticals and Senate Bill 1757 Tom Y. Harrigan, P.E. TCEQ Water Quality Division Wastewater Permitting Section 512/
Toxic New Source Review Lance Ericksen Engineering Division Manager MBUAPCD.
Waste Pharmaceuticals: The Road Forward Improving Patient Safety through Informed Medication Prescribing & Disposal Practices October 31, 2007 David P.
Science and Policy Issues in the Control & Management of Environmental Hazards Introduction Connecting the Dots: Science and Policy Issues in the Control.
What Do Toxicologists Do?
Housekeeping Purpose and goals Meeting times Syllabus Texts –Online Next class reading materials.
P HARMACEUTICALS AND P ERSONAL C ARE P RODUCTS AKEETA HARRIS ABIGAIL DeBOFSKY SIMON CHRISTENSEN.
European Policy for Food Safety Research and Horizon 2020
EPA Office of Water Source Water Protection Initiative Elizabeth Corr, Associate Director Drinking Water Protection Div. Office of Ground Water and Drinking.
EPA/Office of Water’s Strategy for Contaminants of Emerging Concern Octavia Conerly Health and Ecological Criteria Division Office of Water U.S. Environmental.
Environmental Hazards, Risk, & Human Health. Leading Causes of Mortality.
Community Health Risk Assessment An Assessment of Risk Related to the Oil and Gas Industry in Garfield County Teresa A. Coons, PhD Senior Scientist Saccomanno.
Dr. Manfred Wentz Director, Hohenstein Institutes (USA) Head, Oeko-Tex Certification Body (USA) AAFA – Environmental Committee Meeting November 10, 2008.
SMMSS - Support to Modernisation of Mongolia Standardisation System Food Chain Risk Assessment and Management - Seminar on Food Safety Ulaanbaatar / Mongolia.
Chapter 15 Environmental Health, Pollution and Toxicology.
Chapter 15 Environmental Health, Pollution and Toxicology.
Forging Partnerships on Emerging Contaminants November 2, 2005 John Vandenberg Associate Director for Health National Center for Environmental Assessment.
The Perchlorate Contamination Challenge: EPA’s Part in Pro-Active Partnership William H. Farland, Ph.D. Director National Center for Environmental Assessment.
Pharmaceuticals in the Environment Pharmaceuticals are increasingly being designed to have higher potency, bioavailability and degradation resistance.
Emerging Contaminants in the Great Lakes Christina Pfouts.
Human Health and Environmental Risks
1 EPA Regulatory Authority and PPCPs Octavia Conerly Health and Ecological Criteria Division Office of Water Office of Water October 26, 2005 October 26,
Thuan Chau EMERGING CONTAMINANTS PHARMACEUTICALS AND PERSONAL CARE PRODUCTS (PPCPs) “Contaminants of Emerging Concern” (CECs) – EPA University of Utah.
Environmental impact assessment of steroid hormones R. Laenge, LGE 09 June 2006 Assessment of the impact of selected steroid hormones on biodiversity Reinhard.
VI. Purpose of Water Treatment
Introduction to Emerging Contaminants What are Emerging Contaminants?
CALIFORNIA proposed SAFER CONSUMER PRODUCT REGULATIONS Marjorie MartzEmerson October 24, 2012.
An Overview of EDC’s, Pharmaceuticals and Personal Care Products in Our Drinking Water Presented By: Roxanne Russell, Yuh-Chi Niou, Kris McArthur, Amelia.
Risk Assessment 1 Thanks to Paul R. Harp, Ph.D., NH Department of Health & Human Services, US EPA Air Quality Planning & Standards Division, and the DOE.
Reclaimed Wastewater Quality Criteria, Standards, and Guidelines
PPCPs: An Emerging Source of Chemical Pollution By: Arienne Barnes Nicolette Foster Aaron Stover Ingrid Tobar Sara Vogt Jennifer Wolfe.
Pollution and Human Health
Trace Constituents: Red Herring Hysteria No public health risk exists, but hype still does Residuals and Biosolids Management Conference Alan B. Rubin,
Regulatory Chemical Risk Assessment From Superfund to Contaminants of Emerging Concern Where Have We Been and Where Are We Going? Patrick Gwinn November.
Chapter 15.3 Risk Assessment 2002 WHO report: “Focusing on risks to health is the key to preventing disease and injury.” risk assessment—process of evaluating.
Part 1d: Exposure Assessment and Modeling Thomas Robins, MD, MPH.
Chapter 15.1 Links Between Human Health and the Environment emerging diseases (avian flu, SARS, Ebola) appear as we continue to manipulate the natural.
Biodegradation of Emerging Contaminants by Pseudomonas butanorova Shervada Hall Houston Independent School District Empowerment College Preparatory High.
A Global Review of Methodologies for Aquatic Ecological Risk Assessment.
Biological & Research Programs. Overview Status Future Direction.
© 2015 Water Research Foundation. ALL RIGHTS RESERVED. © 2015 Water Research Foundation. ALL RIGHTS RESERVED. No part of this presentation may be copied,
Forging Partnerships on Emerging Contaminants November 2, 2005 Elizabeth Southerland Director of Assessment & Remediation Division Office of Superfund.
Key Concepts on Health Risk Assessment of Chemical Mixtures.
1. Consumers, Health, Agriculture and Food Executive Agency Risk assessment with regard to food and feed safety Risk analysis Why risk assessment in the.
U.S. Department of the Interior U.S. Geological Survey Chemicals of Emerging Environmental Concern: The New Pollutants Herb Buxton USGS Toxic Substances.
Pharmaceuticals in the Great Lakes: prevention priorities Great Lakes Pharmaceutical Stewardship Summit Chicago, IL June 7-8, 2012 Olga Lyandres Research.
MEASUREMENT OF TOXICITY By, Dr. M. David Department of Zoology, Karnatak University Dharwad.
Anniston PCB Site Review of Risk Assessments for OU-1/OU-2
Environmental Effects on Human Health
THE DOSE MAKES THE POISON
A Short Update on Perfluorinated Alkyl Substances (PFAS)
Pollution and Human Health
Predicting elemental toxicity based on perturbations to natural concentrations Advisor: Sarah Jane White.
Apes Ch 11 Risk, Toxicology, and Human Healthy
Environmental Health, Pollution and Toxicology
Technical report on emerging substances
Introduction to Risk Assessment
Presentation transcript:

1 What is in the Water and What are the Risks? Bryan W. Brooks, Ph.D. Associate Professor and Director Environmental Health Science Program Texas Innovative Water 2010, San Antonio

2 What is in the Water and What are the Risks? Today: Focus on Pharmaceuticals and Endocrine Active Compounds Bryan W. Brooks, Ph.D. Associate Professor and Director Environmental Health Science Program Texas Innovative Water 2010, San Antonio

3 We’ve come a long way… “The flow below Dallas for many miles does not impress one as being that of a river. A stench from its inky surface putrescent with the oxidizing processes to which the shadows of the overreaching trees add stygian blackness and the suggestion of some mythological river of death. With this burden of filth the purifying agencies of the stream are prostrated; it lodges against obstruction in the stream and rots, becoming hatcheries for mosquitoes and malaria. A thing of beauty is thus transformed into one of hideous danger.” Texas Department of Health 1924

4 So, What is Risk? Risk – the probability of an adverse outcome Risk assessment – the scientific characterization of potential adverse effects resulting from human and ecological exposures to chemicals or other stressors ExposureToxicity RISK

5 PARACELSUS ( ) “All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy” Toxicity is not Risk

6 So, What is Risk? Risk – the probability of an adverse outcome Risk assessment – the scientific characterization of potential adverse effects resulting from human and ecological exposures to chemicals or other stressors Risk management – the process by which policy actions to deal with the hazards identified in the risk assessment process are selected

7 So, What is Risk? Some common risks – You have a one in a million chance of dying by: - being struck by lightning, or - eating 40 tablespoons of peanut butter, or - having one chest x-ray in any given year The chance of dying in a car accident is 12,000 times greater than the above risks… …but I drove to San Antonio

8 So, What is Risk? Scientists ask questions – Are people/wildlife being exposed to chemicals? What is the magnitude, duration, and frequency of exposure? Are adverse human health / ecological outcomes possible? Citizens ask questions, too – Is the exposure voluntary, is it familiar? Does it have relevance to me, can I control it? What are the severity and immediacy of the effects?

9 So, What is Risk? Scientists ask questions – Are people/wildlife being exposed to chemicals? What is the magnitude, duration, and frequency of exposure? Are adverse human health / ecological outcomes possible? Citizens ask questions, too – Is the exposure voluntary, is it familiar? Does it have relevance to me, can I control it? What are the severity and immediacy of the effects?

10 So, What is Risk? Scientists ask questions – Are people/wildlife being exposed to chemicals? What is the magnitude, duration, and frequency of exposure? Are adverse human health / ecological outcomes possible? Citizens ask questions, too – Is the exposure voluntary, is it familiar? Does it have relevance to me, can I control it? What are the severity and immediacy of the effects?

11 “AP Probe Finds Drugs in Drinking Water” 9 March 2008 Contaminants of “Emerging” Concern?

12 Contaminants of “Emerging” Concern? Pharmaceuticals and Personal Care Products (PPCPs) Heart medications, Antidepressants, Antibiotics, Contraceptives, Antimicrobials, Fragrances, etc Endocrine Disrupting/Modulating Compounds (EDCs) Surfactants, Plasticizers, Pesticides, Steroids, etc PPCPs EDCs 17α-ethinyl estradiol

13 Why are pharmaceuticals/EDCs studied? SPE-GC-MSMS SPE-LC-MSMS We now have the ability to measure chemicals at VERY LOW levels…. ….so we can now report trace concentrations of drugs, etc at below part per trillion levels… ….but are the risks acceptable?

14 What about Human Health? What if a human adult consumes 50 ng/L (parts per trillion) of Drug X in their drinking water? - A human therapeutic dose of Drug X = 50 mg. - The person would need to consume 1,000,000 L to receive a therapeutic dose of Drug X. - If the person consumed 5 L per day, then it would take 548 years to receive one dose of Drug X.

15 What about Human Health? Under the Safe Drinking Water Act, US EPA identifies substances for potential regulation (e.g., MCLs). Several pharmaceuticals were recently placed on US EPA’s Contaminant Candidate List 3. Of these pharmaceuticals, most were endocrine active substances, another was an antibiotic.

16 Brooks et al ET&C Texas Fish can Accumulate Drugs in Edible Tissues…. ….should I stop eating the fish? What about drugs in the fish I catch?

17 National Pilot Study of PPCPs in Fish Tissue for US EPA Ramirez et al ET&C

18 What if a human adult consumes a fish fillet with 50 ng/g (parts per billion) of sertraline, the drug in the antidepressant Zoloft? - One tablet of sertraline HCl = 50 mg sertraline. - A consumption rate of kg/meal is used (EPA). - A person would consume 14.3 μg in one fish meal. - A person would need to consume 3,496.5 meals to receive one therapeutic dose of sertraline. - If a person consumed 1 fish meal per day (from the contaminated site), then it would take almost 10 years to get one daily dose of sertraline.

19 The Public Remains Interested… National Geographic April 2010

20 So, What about Aquatic Life?

21 Ecological Issues Associated with Effluent Water Quality Point source “effluent” water quality evaluated by whole effluent toxicity tests, chemistry, pathogens WQC, prospective assessments use using same organisms Biological integrity evaluated by “ambient” toxicity tests, biotic surveys, biomarkers algae + + Daphnia fish

22 Occurrence Fate Effects Current Knowledge Exposure Effects Where we are now… Where we are going… CECs in Surface Waters

23 Evidence of aquatic life impacts in the field? “There are several cases where strong evidence supports a causal linkage between exposure and effect. Two examples discussed … are organotin-mediated imposex in marine snails and feminization of sewage effluent-exposed male fish.” “Caged fish and laboratory-based exposures confirm that sewage effluent is responsible for the observed increases in vitellogenin (WHO 2002) and reproductive failure (Martinovic et al. 2007).” Hotckiss et al Toxicological Sciences

24 The Type of Chronic Response Matters th centile ACR (79.5) for aquatic toxicants (Raimondo et al 2007) Berninger and Brooks Toxicology Letters Chronic Effects of Some Drugs are much Lower than Traditional Contaminants…

25 Importance of Exposure and Internal Dose Fick et al ES&T Exposure in the Field = Internal dose/Human Cmax ?

26 Fick et al ES&T Zeillinger et al ETC Ex. Levonorgesterel, a synthetic progestin Exposure in the Field + Sub-ppt Effects in the Lab Importance of Exposure and Internal Dose

27 Langdon et al 2010 Integrated Environmental Assessment & Management Biosolids receiving more attention…

28 Aquatic Life Criteria for Contaminants of Emerging Concern – White Paper submitted to EPA Science Advisory Board (SAB) in July 2008 –received comment from SAB in December 2008 – 05F6F2C/$File/EPA-SAB unsigned.pdf Recent EPA Activities

29 Senate Bill 1757 Project SB-1757 passed in Texas 81 st Legislative Session, The Texas Commission on Environmental Quality (TCEQ) shall study and make recommendations regarding the methods to be used by consumers, health care providers, and others for disposing of unused pharmaceuticals so that they do not enter a wastewater system. Report due to legislature December 1, 2010.

30 Brooks et al Environmental Toxicology and Chemistry Selecting Compounds for Management / Monitoring Prioritization of Ecological Hazard/Risk Aquatic and Terrestrial Fate and Exposure: Experimental and Modeling Ecologically Relevant Traditional and Alternative Measures of Effect Environmental Monitoring and Risk Management

31 So, Where Are We Going? Lessons learned from pharmaceuticals/EDCs –Urban water resources is the new normal - public connection Risk Assessment must inform Risk Management –Biological effects  Treatment technologies Exposure to pharmaceuticals and EDCs in drinking water appear to present very low relative risk More studies are needed for other chemicals (e.g., disinfection byproducts, flame retardants), and mixtures Adverse effects on aquatic life are possible, particularly in Texas. Many regulatory agencies around the globe are presently prioritizing risks and chemicals for more study

32 SETAC Globe 10(4): 4. Some more of my thoughts… Brooks et al ETC. OPEN ACCESS! Thank You!